Retinal Fundus Camera Evaluation

Sponsor
Topcon Medical Systems, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT02293174
Collaborator
(none)
10
1
4
2.5

Study Details

Study Description

Brief Summary

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.

Condition or Disease Intervention/Treatment Phase
  • Device: Topcon TRC-NW400
  • Device: TRC-NW8
  • Device: TRC-NW400
  • Device: Canon-CR2
  • Device: Zeiss Visucam PRO

Detailed Description

Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera. While also comparing the images to other manufacturer's retinal cameras

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
TRC-NW400 Retinal Fundus Camera Image Evaluation and Instrument Comparison Protocol
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Normal Healthy Eyes

Willing and able subjects with normal and healthy eyes

Device: Topcon TRC-NW400
Retinal Fundus Camera

Device: TRC-NW8
Retinal Fundus Camera

Device: TRC-NW400
Retinal Fundus Camera

Device: Canon-CR2
Retinal Fundus Camera

Device: Zeiss Visucam PRO
Retinal Fundus Camera

Outcome Measures

Primary Outcome Measures

  1. Fundus Image Grading [1 Hour]

    Determining the best display to reflect the real color of the retina

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Subjects with no known ocular diseases
Exclusion Criteria:
  • Subjects with known ocular diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Topcon Medical Systems, Inc. Oakland New Jersey United States 07436

Sponsors and Collaborators

  • Topcon Medical Systems, Inc.

Investigators

  • Principal Investigator: Danny Leung, Clinical Trial Manager

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Topcon Medical Systems, Inc.
ClinicalTrials.gov Identifier:
NCT02293174
Other Study ID Numbers:
  • TOPCON-003-2014
First Posted:
Nov 18, 2014
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022

Study Results

No Results Posted as of Jun 8, 2022